Last reviewed · How we verify

A Four Arm, Single-Dose, Food Effect Evaluation With 105 mg Fenofibric Acid Tablets Administered in a Fasted State and Three Different Fed Conditions, Low-Fat/Low Calorie Meal, Standard Meal, and High-Fat/High Calorie Meal

NCT00960856 Phase 1 COMPLETED Results posted

The primary objective of this study is to characterize the single-dose pharmacokinetic profile of fenofibric acid (105 mg tablets) and the effect of food of various calorie/fat compositions on the rate and extent of absorption. Additionally, the safety and tolerability of this dose and regimen of fenofibric acid will be evaluated.

Details

Lead sponsorMutual Pharmaceutical Company, Inc.
PhasePhase 1
StatusCOMPLETED
Enrolment40
Start date2007-11
Completion2007-11

Conditions

Interventions

Primary outcomes

Countries

United States